List of bibliographic references indexed by Dopamine Agents (therapeutic use)
Number of relevant bibliographic references: 77.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000128 (2015) |
Marjan Jahanshahi [Royaume-Uni] ; Ignacio Obeso ; Christelle Baunez ; Manuel Alegre ; Paul Krack | Parkinson's disease, the subthalamic nucleus, inhibition, and impulsivity. |
| 000213 (2015) |
Oscar S. Gershanik [Argentine] | Improving L-dopa therapy: the development of enzyme inhibitors. |
| 000732 (2013) |
Ralf Reilmann [Allemagne] | The pridopidine paradox in Huntington's disease. |
| 000861 (2013) |
Alex A. Macdonald [Canada] ; Oury Monchi ; Ken N. Seergobin ; Hooman Ganjavi ; Ruzbeh Tamjeedi ; Penny A. Macdonald | Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function. |
| 000917 (2013) |
Joseph Jankovic [États-Unis] | Medical treatment of dystonia. |
| 000973 (2013) |
Aikaterina Angeli [Royaume-Uni] ; Niccolo E. Mencacci [Royaume-Uni, Italie] ; Raquel Duran [Royaume-Uni] ; Iciar Aviles-Olmos [Royaume-Uni] ; Zinovia Kefalopoulou [Royaume-Uni] ; Joseph Candelario [Royaume-Uni] ; Sarah Rusbridge [Royaume-Uni] ; Jennifer Foley [Royaume-Uni] ; Priyanka Pradhan [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Tom Foltynie [Royaume-Uni] | Genotype and phenotype in Parkinson's disease: Lessons in heterogeneity from deep brain stimulation |
| 000B26 (2013) |
| A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease. |
| 000B63 (2012) |
Katrina L. Paumier [États-Unis] ; Andrew D. Siderowf ; Peggy Auinger ; David Oakes ; Lalitha Madhavan ; Alberto J. Espay ; Fredy J. Revilla ; Timothy J. Collier | Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease. |
| 000D72 (2012) |
Jessie Theuns [Belgique] ; David Crosiers ; Luc Debaene ; Karen Nuytemans ; Bram Meeus ; Kristel Sleegers ; Dirk Goossens ; Ellen Corsmit ; Ellen Elinck ; Karin Peeters ; Maria Mattheijssens ; Barbara Pickut ; Jurgen Del-Favero ; Sebastiaan Engelborghs ; Peter Paul De Deyn ; Patrick Cras ; Christine Van Broeckhoven | Guanosine triphosphate cyclohydrolase 1 promoter deletion causes dopa-responsive dystonia. |
| 001245 (2011) |
Ashley H. Spencer [Royaume-Uni] ; Hugh Rickards ; Alfonso Fasano ; Andrea E. Cavanna | The prevalence and clinical characteristics of punding in Parkinson's disease. |
| 001393 (2011) |
Francisco J. Palomar [Espagne] ; Francisco Díaz-Corrales [Espagne] ; Fatima Carrillo [Espagne] ; Miguel Fernández-Del-Olmo [Espagne] ; Giacomo Koch [Italie] ; Pablo Mir [Espagne] | Sensory perception changes induced by transcranial magnetic stimulation over the primary somatosensory cortex in Parkinson's disease |
| 001403 (2011) |
Alfonso Fasano [Italie] ; Alessandro Di Matteo [Italie] ; Carmine Vitale [Italie] ; Giovanna Squintani [Italie] ; Laura Ferigo [Italie] ; Federica Bombieri [Italie] ; Gabriella Santangelo [Italie] ; Marianna Amboni [Italie] ; Paolo Barone [Italie] ; Michele Tinazzi [Italie] | Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy |
| 001459 (2011) |
Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline M. Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada] | Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts |
| 001562 (2011) |
Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] | Milestones in Parkinson's disease therapeutics |
| 001703 (2011) |
Thomas D. H Lbig [États-Unis, Allemagne] ; Stephanie Assuras [États-Unis] ; Judy Creighton [États-Unis] ; Joan C. Borod [États-Unis] ; Winona Tse [États-Unis] ; Pasquale G. Frisina [États-Unis] ; Andrei Voustianiouk [États-Unis] ; Jean-Michel Gracies [États-Unis] ; C. Warren Olanow [États-Unis] | Differential role of dopamine in emotional attention and memory: Evidence from Parkinson's disease |
| 001717 (2011) |
Raul Martínez-Fernández [Royaume-Uni, Espagne] ; Ludvic Zrinzo [Royaume-Uni] ; Iciar Aviles-Olmos [Royaume-Uni] ; Marwan Hariz [Royaume-Uni, Suède] ; Irene Martinez-Torres [Royaume-Uni, Espagne] ; Eileen Joyce [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Thomas Foltynie [Royaume-Uni] | Deep brain stimulation for Gilles de la Tourette syndrome: A case series targeting subregions of the globus pallidus internus |
| 001809 (2011) |
Francesca Assogna [Italie] ; Luca Cravello [Italie] ; Carlo Caltagirone [Italie] ; Gianfranco Spalletta [Italie] | Anhedonia in Parkinson's disease: A systematic review of the literature |
| 001944 (2010) |
Tom H. Johnston [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Juha-Matti Savola [Suisse] ; Jonathan M. Brotchie [Canada] | The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates |
| 001983 (2010) |
Matthis Synofzik [Allemagne] ; Friedrich Asmus [Allemagne] ; Matthias Reimold [Allemagne] ; Ludger Schöls [Allemagne] ; Daniela Berg [Allemagne] | Sustained dopaminergic response of parkinsonism and depression in POLG‐associated parkinsonism |
| 001A18 (2010) |
A. Jon Stoessl [Canada] | Scans without evidence of dopamine deficiency: The triumph of careful clinical assessment |
| 001B07 (2010) |
Victoria Newsway [Royaume-Uni] ; Mark Fish [Royaume-Uni] ; Jonathan D. Rohrer [Royaume-Uni] ; Elisa Majounie [Royaume-Uni] ; Nigel Williams [Royaume-Uni] ; Melissa Hack [Royaume-Uni] ; Jason D. Warren [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] | Perry syndrome due to the DCTN1 G71R mutation: A distinctive levodopa responsive disorder with behavioral syndrome, vertical gaze palsy, and respiratory failure |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dopamine Agents (therapeutic use)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i \
-Sk "Dopamine Agents (therapeutic use)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdEn.i
|clé= Dopamine Agents (therapeutic use)
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
